Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-20

Clinical Trial Update: Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing a chewable form to a swallowable tablet of mebendazole for hookworm infections; results completed with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mebendazole (Mebendazole)

Snippet

Sponsor: Swiss Tropical & Public Health Institute | Conditions: Hookworm Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-07-20